Kinesins have been recently highlighted as prognostic biomarkers in breast cancer [23,24] and a 6-KIFs-based risk score (including four MT-Rel genes, KIF4A, KIF15, KIF18B, KIF20A) was reported to accurately predict outcomes [24]. This evidence concerns the gene KIF18B and breast carcinoma.